Written question asked by Paul Burstow (Liberal Democrat) on Wednesday, 2 April 2003, in the House of Commons. It was due for an answer on Wednesday, 9 April 2003. It was answered by David Lammy (Labour) on Wednesday, 9 April 2003 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what information his Department collects from the School of Health and Related Research at the University of School of Health and Related Research at the University of Sheffield regarding the risk sharing agreement for beta interferon and glatiramer.

Answer: Mr. Burstow: To ask the Secretary of State for Health what information his Department collects from the School of Health and Related Research at the University of Sheffield regarding the risk sharing agreement for beta interferon and glatiramer. [107569] Mr. Lammy: The Sheffield University School for Health and Related Research (ScHARR) is responsible for collecting and analysing information on health outcomes for patients who receive disease-modifying therapies for multiple sclerosis (MS) under the United Kingdom risk sharing scheme. Information relating to progress in setting up the network of centres who will be providing data to ScHARR is routinely provided to members of the project monitoring group representing the parties to the scheme, including professional bodies, the MS Society and MS Trust, the companies marketing the four products, and UK health departments. ScHARR is not responsible for wider aspects of implementation of the scheme.

Secondary information

Type: Written question
Reference: 107569; 403 c317-8W
Session: 2002-03
Subjects: Health services Drugs Medical treatments Prescription drugs Multiple sclerosis Research Interferon beta Glatiramer acetate University of Sheffield
Link: View this Written question on www.publications.parliament.uk